Filing Flows › ResMed (RMD) › Guidance & outlook
ResMed (RMD) guidance and outlook
ResMed (RMD) gave its guidance on Oct 29, 2026: Revenue +5% to +7% for FY2027. ResMed's 10-Q filed Oct 30, 2026 makes 6 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2027 | +5% to +7% | new |
From the earnings release filed Oct 29, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Oct 30, 2026
- We continue to experience inflationary pressure on our manufacturing inputs, particularly electronic components, and expect these pressures to continue through the remainder of fiscal year 2027.
- We expect that cash provided by operating activities may fluctuate in future periods as a result of several factors, including fluctuations in our operating results, which include supply chain disruptions, working capital requirements and capital deployment decisions.
- If we are required to access the debt market, we believe that we will be able to secure reasonable borrowing rates.
- As part of our liquidity strategy, we will continue to monitor our current level of earnings and cash flow generation as well as our ability to access the market considering those earning levels.
- Final settlement of the ASR Agreement is expected to occur no later than December 29, 2026, and will be based on a discount to the volume-weighted average price per share of our common stock over the term of the ASR Agreement.
- We expect to satisfy all of our liquidity and remaining long-term debt requirements through a combination of cash on hand, cash generated from operations and debt facilities.
ResMed's latest quarter
ResMed, Q1 FY27: revenue $1.4B (+6% year over year), operating margin 32.0%, net earnings $418M, operating cash flow $422M. The chart follows the revenue to costs, profit and cash.
Questions
Did ResMed raise or lower its guidance?
ResMed (RMD) gave its guidance on Oct 29, 2026: Revenue +5% to +7% for FY2027.
What does ResMed expect?
We continue to experience inflationary pressure on our manufacturing inputs, particularly electronic components, and expect these pressures to continue through the remainder of fiscal year 2027. We expect that cash provided by operating activities may fluctuate in future periods as a result of several factors, including fluctuations in our operating results, which include supply chain disruptions, working capital requirements and capital deployment decisions. If we are required to access the debt market, we believe that we will be able to secure reasonable borrowing rates.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.